en

PRODUCT DETAIL

Sunitinib G.L. Pharma 50 mg tvrdé kapsuly

Code 6609D
MA number 44/0031/21-S
Product Form: cps dur 28x50 mg (blis.Al/OPA/Al/PVC)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX01 Sunitinib
Shelf life: 36
Container: blister Al/OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 25.03.2021
Validity: 25.03.2026
PIL: PIL_Sunitinib G.L. Pharma 50 mg tvrdé kapsuly_03/2021.pdf  
SPC: SPC_Sunitinib G.L. Pharma 50 mg tvrdé kapsuly_11.2021.pdf  
Safety feature Yes
Data update: 24.11.2021
eu-flag.png sk-flag.png